Zhang, Xiaoyun http://orcid.org/0000-0002-4132-3573
Spiegel, Jochen http://orcid.org/0000-0001-7641-1066
MartÃnez Cuesta, Sergio http://orcid.org/0000-0001-9806-2805
Adhikari, Santosh http://orcid.org/0000-0002-1501-2106
Balasubramanian, Shankar http://orcid.org/0000-0002-0281-5815
Funding for this research was provided by:
Cancer Research UK (C9681/A29214, C9545/A19836)
Welcome Trust
Article History
Received: 20 January 2021
Accepted: 18 May 2021
First Online: 28 June 2021
Competing interests
: S.B. is a founder and shareholder of Cambridge Epigenetix Ltd. S.M.C. and S.A. are now employees of AstraZeneca. All the other authors have no competing interests.